Sector portfolio · Government fund · China

Shenzhen Capital Group Co.'s Biotech portfolio

Shenzhen Capital Group Co. has backed 16 Biotech startups in rounds we track, $851M between them, shown by the stage each has reached. The best-funded is Mabplex International.

16startups backed
4stages
$851Mraised between them
Series Bbiggest stage

Shenzhen Capital Group Co.'s whole portfolioShenzhen Capital Group Co.'s profile

Series B

6

Series C and later

5

Series A

3

Stage not reported

2

Segment by segment

Series B

6 startups · $266M raised

  1. MabPlex InternationalMabPlex provides CDMO services in the development and manufacturing of biopharmaceuticals.China$130M
  2. CodoonCodoon is a sports and wellness service provider offering products that monitor users' sport, sleeping and other physical conditions.China$61M
  3. LLachesisChina$51M
  4. Transcend VivoscopeTranscend Vivoscope is a biotechnology company that specializes in providing advanced microscopy imaging products and solutions.-$15M
  5. Salus BioMedSalus Biomed, officially known as Shenzhen Salus Biomed Technology Co., Ltd., is a biotechnology company founded in October 2020 aChina$7.0M
  6. Xunda PharmaceuticalHubei Xunda Pharmaceutical is a producer of anti-inflammatory and analgesic drugs, and bulk pharmaceutical chemicals for antibiotics.China$2.4M

Series C and later

5 startups · $433M raised

  1. Virogin BiotechVirogin Biotech is a clinical-stage immuno-oncology company based in Richmond/Vancouver, British Columbia, Canada.Canada$120M
  2. GenFleet TherapeuticsGenFleet Therapeutics is a biotechnology developer and researcher of molecular pharmaceuticals targeting cancer treatments.China$96M
  3. TTeligeneTeligene is a drug discovery company edicating to developing innovative small-molecule drugs.China$93M
  4. ABAccro BioscienceChina$64M
  5. LTLaekna TherapeuticsLaekna Therapeutics is a biotech company focusing on drug discovery and development.China$61M

Series A

3 startups · $58M raised

  1. EEnrikenuoEnrikenuo is a biotechnology company that focuses on the research and development of new generation CAR-NK technology based cell drugs.China$28M
  2. LLidakangChina$16M
  3. SPSt Phi TherapeuticsYizun Biotechnology is a cutting-edge immune cell therapy company that has developed many unique platform technologies.China$14M

Stage not reported

2 startups · $94M raised

  1. ZZelgenChina$62M
  2. HaploX BiotechnologyHaploX Biotechnology is a genetic testing and precision medicine company based in Shenzhen, Guangdong, China.China$32M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Shenzhen Capital Group Co. as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioShenzhen Capital Group Co.'s Hardware & Electronics portfolio12 startups · $851MPortfolio mapShenzhen Capital Group Co. portfolio map85 startups · $12BCo-investorsWho invests with Shenzhen Capital Group Co.27 co-investorsSector portfolioY Combinator's AI portfolio1,143 startups · $44BSector portfolioY Combinator's Fintech portfolio338 startups · $24BSector portfolioTechstars' AI portfolio336 startups · $4.9B

Raising from investors like Shenzhen Capital Group Co.?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps